Clinical trial
Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
NCT02221154 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
- Lead sponsor
- Centre Hospitalier Departemental Vendee
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 30, 2014
- Completion date
- May 22, 2017
- Enrollment
- 49 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.